To further elucidate the mechanisms of action of eIF4A inhibitors in HCC cell lines, we selected the two most effective drugs, i.e., CR-1-31-B and Zotatifin, for the following experiments. This evidence concerns the gene EIF4A1 and hepatocellular carcinoma.